{"id":207188,"name":"CARDIOL THERAPEUTICS","slug":"cardiol-therapeutics","state":null,"country":"Canada","description":"clinical stage biotech co. developing innovative therapies for inflammatory heart disease","totalSpending":310000,"filings":9,"yearlySpending":[{"year":2020,"income":30000},{"year":2021,"income":160000},{"year":2022,"income":120000}],"issues":["MED"],"firms":["RYAN COSTELLO STRATEGIES"],"lobbyists":["RYAN COSTELLO"],"govEntities":["Drug Enforcement Administration (DEA)","HOUSE OF REPRESENTATIVES","SENATE","Natl Institutes of Health (NIH)"],"sampleDescriptions":["DEA's Interim Final Rule on 2018 Farm Bill as it relates to CBD, and Cardiol's Phase 2/3 FDA IND approved clinical trial for potential covid therapeutic.","Determining the control status of synthetically derived cannabidoil from the language and intent of the Implementation of the Agriculture Improvement Act of 2018.","No specific lobbying issues this quarter, determining applicable research grant opportunities","No specific lobbying issues this quarter, determining applicable research grant opportunities","No specific lobbying issues this quarter."],"years":[2020,2021,2022]}